D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ZYNE holding history
Zynerba Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZYNE overviewAll 13F holders of ZYNEFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −195,064−100.0% | Sold out | Holders |
| Q4 2022 | 195,064 | $103.4K | <0.1% | −372,052−65.6% | Reduced | Holders |
| Q3 2022 | 567,116 | $415.0K | <0.1% | −542,039−48.9% | Reduced | Holders |
| Q2 2022 | 1,109,155 | $1.26M | <0.1% | −99,725−8.2% | Reduced | Holders |
| Q1 2022 | 1,208,880 | $2.48M | <0.1% | +51,468+4.4% | Added | Holders |
| Q4 2021 | 1,157,412 | $3.33M | <0.1% | −248,577−17.7% | Reduced | Holders |
| Q3 2021 | 1,405,989 | $5.96M | <0.1% | +332,989+31.0% | Added | Holders |
| Q2 2021 | 1,073,000 | $5.68M | <0.1% | +765,962+249.5% | Added | Holders |
| Q1 2021 | 307,038 | $1.43M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.